MichaelJamesWelshMD
Pulmonology • Iowa City, IAPleural Disease
Professor, Internal Medicine, University of Iowa College of Medicine
Are you Dr. Welsh?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 35 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 Hawkins Dr
Iowa City, IA 52242Phone+1 319-358-4187Fax+1 319-353-6406- Is this information wrong?
Summary
- Dr. Michael Welsh, MD is a pulmonologist in Iowa City, Iowa. He is currently licensed to practice medicine in Iowa. He is affiliated with University of Iowa Hospitals and Clinics and is a Professor at University of Iowa College of Medicine.
Education & Training
University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 1974 - 1977
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1974
Certifications & Licensure
IA State Medical License 1975 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Elected Member Institute of Medicine, 1997
- Elected Member The American Society for Clinical Investigation, 1984
- Investigator Howard Hughes Medical Institute
Publications & Presentations
PubMed
- 3 citationsWNK Inhibition Increases Surface Liquid pH and Host Defense in Cystic Fibrosis Airway Epithelia.Tayyab Rehman, Philip H Karp, Andrew L Thurman, Steven E Mather, Akansha Jain, Ashley L Cooney, Patrick L Sinn, Alejandro A Pezzulo, Michael E Duffey, Michael J Welsh> ;American Journal of Respiratory Cell and Molecular Biology. 2022 Oct 1
- 11 citationsA pilot to assess target engagement of terazosin in Parkinson's diseaseJordan L. Schultz, Jia Xu, Sarah E. Ernst, Fariba Tayyari, Lei Liu, Ergun Y. Uc, Eric B. Taylor, Jacob E. Simmering, Vincent A. Magnotta, Michael J. Welsh, Nandakumar ...> ;Parkinsonism & Related Disorders. 2021 Nov 27
- 22 citationsInflammatory cytokines TNF-α and IL-17 enhance the efficacy of cystic fibrosis transmembrane conductance regulator modulatorsTayyab Rehman, Philip H. Karp, Ping Tan, Brian J Goodell, Alejandro A. Pezzulo, Andrew L Thurman, Ian M. Thornell, S.L. Durfey, Michael E. Duffey, David A. Stoltz, Edw...> ;The Journal of Clinical Investigation. 2021 Aug 16
- Join now to see all
Press Mentions
Welsh Wins 2022 Shaw Prize in Life Sciences and MedicineMay 25th, 2022- Drug That Treats an Enlarged Prostate May 'Slow Disability' in Parkinson's SufferersSeptember 16th, 2019
Big Data, Bench Science Suggests Drug May Slow Parkinson's Progression in PeopleSeptember 16th, 2019
Hospital Affiliations
University of Iowa Hospitals and ClinicsIowa City, Iowa
